Abstract
Background: Systemic reactivation of herpesviruses may occur in intensive care unit (ICU) patients and is associated with morbidity and mortality. Data on severe Coronavirus disease-19 (COVID-19) and concomitant reactivation of herpesviruses are lacking.
Methods: We selected patients admitted to ICU for confirmed COVID-19 who underwent systematic testing for Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human-herpes virus-6 (HHV-6) DNAemia while in the ICU. We retrospectively analysed frequency, timing, duration and co-occurrence of viral DNAemia.
Results: Thirty-four patients were included. Viremia with EBV, CMV, and HHV-6 was detected in 28 (82%), 5 (15%), and 7 (22%) patients, respectively. EBV reactivation occurred early after ICU admission and was associated with longer ICU length-of-stay.
Conclusions: While in the ICU, critically ill patients with COVID-19 are prone to develop reactivations due to various types of herpesviruses.
Keywords: COVID-19; Cytomegalovirus; Epstein–Barr virus.
【저자키워드】 COVID-19, cytomegalovirus, Epstein–Barr virus., 【초록키워드】 coronavirus disease, intensive care, intensive care unit, virus, ICU, Critically ill, Viremia, morbidity, Patient, ICU admission, Epstein-Barr virus, cytomegalovirus, CMV, morbidity and mortality, herpesvirus, patients, EBV, HHV-6, Frequency, Epstein–Barr virus, systemic, Critically ill patient, severe coronavirus disease, while, herpesviruses, selected, develop, occurred, analysed, occur, admitted to ICU, co-occurrence, with COVID-19, 【제목키워드】 virus, incidence, Critically ill patient, with COVID-19,